Agree the clinical, digital and information-governance review before any live use.
Wai Clinicians is ambient voice technology. It drafts the note, letters and codes from the consultation, in 60 languages, for the clinician to review and sign. There is no single NHS approval for ambient voice technology, and NHS England’s AVT Supplier Registry is a self-certified list, not a framework or an endorsement. Your organisation checks the supplier’s DTAC, DCB0129 clinical safety work and DSPT position, and completes its own DCB0160 and DPIA. Wai shares its clinical safety materials and DSPT position for your intended use in a scoped review, each with a status and a date. One clinician is $350 a month on the pricing page, and the form below starts the review.
Assess how drafts are created, reviewed and signed for your proposed pathway.
Review the approval and exception rules for each patient-facing workflow before use.
Define responsibility for results, follow-up and escalation with the care team.
Agree the hosting, access and data-processing terms for your organisation.
Agree the manufacturer and deploying organisation responsibilities, the safety evidence and any open work for your intended use.
Check the approval rules, automated actions and exception handling for the proposed pathway.
Agree the hosting, access and processing terms with your information-governance team.
Your clinical safety team sees the intended use, the evidence and the review process before anything goes live.
You decide which actions need a person’s approval.
Review the applicable clinical safety, data protection, technical assurance, interoperability and accessibility requirements for your intended use.
Your team gets the current evidence and scope from a named reviewer, with any open items set out.
You agree how data flows and who can see it.
There is no single NHS approval for ambient voice technology. NHS England's AVT Supplier Registry is a national self-certified list, and NHS England says it is not a commercial framework and does not endorse the suppliers on it. Each organisation checks a supplier against the national and local requirements agreed through its ICB or region before any agreement.
On 29 July 2026 the MHRA published guidance, developed with NHS England, that AVT products intended only to transcribe and summarise clinical conversations, draft correspondence or suggest clinical codes for a clinician to review are not regulated as medical devices. Products that support diagnosis or take automated clinical action still are. Wai is not registered as a medical device, so agree an intended use that does not need one.
The supplier's DTAC, its DCB0129 clinical safety work and its DSPT position. The organisation completes its own DCB0160 work with a named Clinical Safety Officer, and a DPIA. Wai shares its clinical safety materials and DSPT position for your intended use in a scoped review, each with a status and a date, including any open work.
Most primary care buying is a local or ICB agreement. NHS Shared Business Services runs Digital Dictation, Speech Recognition and Outsourced Transcription 2, a framework to 30 September 2027 that covers ambient voice technology. A framework is a way to contract, and the assurance work above still applies.
Clinician prices are published on the pricing page, per clinician a month in US dollars. For a trust, ICB or practice, send the pathway you have in mind with the form on this page, and the team arranges a scoped review and the pilot terms.
The full reading, with sources, is in AI scribes in the NHS and how an NHS organisation buys an AI scribe.
Tell us the pathway you are considering. We can arrange a scoped discussion with the relevant clinical, digital and procurement teams.
Ask for relevant Wai assurance materials through our team. Procurement information is on the public sector page.